Phase IV White Papers & Case Studies

  1. Phase IV Clinical Trials Brochure 5/29/2013

    INC Research/inVentiv Health Late Stage leaders help world–class companies bridge the gap from development to commercialization.

  2. Top Nine Opportunities For Improving Observational Research 5/29/2013

    We recently received a Request for Proposal (RFP) from a large pharmaceutical company for an Observational Study to be conducted over the course of five years in several countries worldwide, involving hundreds of sites and thousands of patients. By Jeff Trotter, Executive Director, Phase IV Development

  3. Future Trends For Online EDC In Clinical Studies: INTrial© Application On PCs, Tablets and Smartphones 5/15/2013

    The positive effect of electronic data capture (EDC) on the increase of data quality and on the decrease of time to generate clean data is well known. Today the question no longer is “Shall we use EDC instead of paper work?” but to gain insight in the advantages and pitfalls of the various solutions available.

  4. Switching EDC Platforms To Rescue In-Flight Clinical Trials 5/7/2013

    The decision to switch an EDC platform for in-flight trials is not easy and is fraught with risks. A majority of companies continue to plough forward with higher costs and operational pains due to a failing EDC platform. Read this white paper and learn how Acceliant's low-risk EDC migration can deliver legacy EDC retirement, lower operating costs, and peace of mind for all teams working towards the success of a clinical trial. By Ven Thangaraj, CTO, Acceliant

  5. Brochure: Norwich Clinical Services 2/1/2013

    Norwich Clinical Services is a contract research organization that provides Bioanalytical Services, Pharmacovigilance and Clinical Research Programs to the pharmaceutical and biotech industries.

  6. Therapeutic Expertise: Neuroscience & CNS Datasheet 3/27/2012
    PRA is a leader in the clinical research industry, providing innovative solutions for CNS drug development.
  7. Persistence Leads To High Enrollment: PRA Convinces Client To Stick With Recruitment Strategies 2/21/2012

    PRA was contracted by a large biotech client to evaluate the immunogenicity of a flu vaccine in adult subjects with rheumatoid arthritis. From the start, the PRA study team faced a shortened enrollment period and other timeline challenges, including the protocol’s late delivery as well as problems with the vaccine’s availability. 

  8. Clinical Trials In Russia 8/26/2011
    The Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (Roszdravnadzor) and the Ministry of Health and Social Development of the Russian Federation (MoH) approved 492 new clinical trials of all types including local and bioequivalence studies during 2010, demonstrating a 15% decrease from the last year figure.